Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Kalichman L, Kobyliansky E
H.LeeH.ParkC.HongS
The 1993 animal research showing equivalent follicle effects provides foundational evidence, while more recent delivery system studies demonstrate GHK-Cus potential for superior results with optimized formulations
The dosing structure below is community-derived from each compound's Phase 2/3 data plus the Valdecantos 2024 preclinical synergy paper
Combining IV therapy with occasional injections may help manage long term costs for some individuals
US$ 24.75
US$ 22.16
US$ 26.84
US$ 24.89
US$ 20.93
US$ 28.19
